Skip to main content

Main menu

  • Home
  • Current issue
  • Early View
  • Archive
  • For authors
    • Instructions for authors
    • Submit a manuscript
    • ERS Author FAQs
    • COVID-19 submission information
  • Alerts
  • Subscriptions
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

User menu

  • Log in
  • Subscribe
  • Contact Us
  • My Cart

Search

  • Advanced search
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

Login

European Respiratory Society

Advanced Search

  • Home
  • Current issue
  • Early View
  • Archive
  • For authors
    • Instructions for authors
    • Submit a manuscript
    • ERS Author FAQs
    • COVID-19 submission information
  • Alerts
  • Subscriptions

Pulmonary pharmacology and therapeutics

  • Pulmonary pharmacology and therapeutics
  • Clinical effectiveness of once-daily fluticasone furoate/umeclidinium/vilanterol in usual practice: the COPD INTREPID study design
    Sally Worsley, Neil Snowise, David M.G. Halpin, Dawn Midwinter, Afisi S. Ismaila, Elaine Irving, Leah Sansbury, Maggie Tabberer, David Leather, Chris Compton
    ERJ Open Research Oct 2019, 5 (4) 00061-2019; DOI: 10.1183/23120541.00061-2019
  • A randomised single-centre trial of inhaled liposomal cyclosporine for bronchiolitis obliterans syndrome post-lung transplantation
    Aldo Iacono, Marniker Wijesinha, Keshava Rajagopal, Natalia Murdock, Irina Timofte, Bartley Griffith, Michael Terrin
    ERJ Open Research Oct 2019, 5 (4) 00167-2019; DOI: 10.1183/23120541.00167-2019
  • Prevalence of oral corticosteroid use in the German severe asthma population
    Christian Taube, Peter Bramlage, Annette Hofer, Dörte Anderson
    ERJ Open Research Oct 2019, 5 (4) 00092-2019; DOI: 10.1183/23120541.00092-2019
  • Corticosteroid tapering with benralizumab treatment for eosinophilic asthma: PONENTE Trial
    Andrew Menzies-Gow, Jonathan Corren, Elisabeth H. Bel, Jorge Maspero, Liam G. Heaney, Mark Gurnell, Peter Wessman, Ubaldo J. Martin, Shahid Siddiqui, Esther Garcia Gil
    ERJ Open Research Jul 2019, 5 (3) 00009-2019; DOI: 10.1183/23120541.00009-2019
  • Comparison of intrapleural use of urokinase and tissue plasminogen activator/DNAse in pleural infection
    Benoît Bédat, Jérôme Plojoux, Jade Noel, Anna Morel, Jonathan Worley, Frédéric Triponez, Wolfram Karenovics
    ERJ Open Research Jul 2019, 5 (3) 00084-2019; DOI: 10.1183/23120541.00084-2019
  • Comparative effectiveness of triple therapy versus dual bronchodilation in COPD
    Jaco Voorham, Massimo Corradi, Alberto Papi, Claus F. Vogelmeier, Dave Singh, Leonardo M. Fabbri, Marjan Kerkhof, Janwillem H. Kocks, Victoria Carter, David Price
    ERJ Open Research Jul 2019, 5 (3) 00106-2019; DOI: 10.1183/23120541.00106-2019
  • Antiplatelet therapy in the primary prevention of cardiovascular disease in patients with chronic obstructive pulmonary disease: a randomised controlled proof-of-concept trial
    Vijay Kunadian, Nina Wilson, Deborah D. Stocken, Hani Ali, Elaine McColl, Graham Burns, Nicola Howe, Andrew Fisher, Anthony De Soyza
    ERJ Open Research Jul 2019, 5 (3) 00110-2019; DOI: 10.1183/23120541.00110-2019
  • Clinical development of triple-combination CFTR modulators for cystic fibrosis patients with one or two F508del alleles
    Jennifer L. Taylor-Cousar, Marcus A. Mall, Bonnie W. Ramsey, Edward F. McKone, Elizabeth Tullis, Gautham Marigowda, Charlotte M. McKee, David Waltz, Samuel M. Moskowitz, Jessica Savage, Fengjuan Xuan, Steven M. Rowe
    ERJ Open Research Apr 2019, 5 (2) 00082-2019; DOI: 10.1183/23120541.00082-2019
  • Amikacin exposure and susceptibility of macrolide-resistant Mycobacterium abscessus
    Shelby Daniel-Wayman, Shamira Shallom, Nabila Azeem, Kenneth N. Olivier, Adrian M. Zelazny, D. Rebecca Prevots
    ERJ Open Research Apr 2019, 5 (2) 00154-2018; DOI: 10.1183/23120541.00154-2018
  • Effects of nintedanib in patients with idiopathic pulmonary fibrosis by GAP stage
    Christopher J. Ryerson, Martin Kolb, Luca Richeldi, Joyce Lee, Daniel Wachtlin, Susanne Stowasser, Venerino Poletti
    ERJ Open Research Apr 2019, 5 (2) 00127-2018; DOI: 10.1183/23120541.00127-2018

Pages

  • Previous
  • Next
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • Acute lung injury and critical care (21)
  • Asthma and allergy (108)
  • CF and non-CF bronchiectasis (71)
  • COPD and smoking (186)
  • Epidemiology, occupational and environmental lung disease (42)
  • Genetics (12)
  • Interstitial and orphan lung disease (93)
  • Lung biology and experimental studies (43)
  • Lung cancer (51)
  • Lung imaging (24)
  • Lung structure and function (47)
  • Mechanisms of lung disease (4)
  • Paediatric pulmonology (53)
  • Pulmonary pharmacology and therapeutics (58)
  • Pulmonary vascular disease (36)
  • Respiratory clinical practice (69)
  • Respiratory infections and tuberculosis (161)
  • Sleep medicine (37)

Custom Text goes here

  • Most Read
  • Twitter
Loading
  • Persistent symptoms 3 months after a SARS-CoV-2 infection: the post-COVID-19 syndrome?
  • Pneumomediastinum and subcutaneous emphysema in COVID-19: barotrauma or lung frailty?
  • IQOS exposure impairs human airway cell homeostasis: direct comparison with traditional cigarette and e-cigarette
  • Veno-venous extracorporeal membrane oxygenation in coronavirus disease 2019: a case series
  • COVID-19 in children with underlying chronic respiratory diseases: survey results from 174 centres
More...

Navigate

  • Home
  • Current issue
  • Archive

About ERJ Open Research

  • Editorial board
  • Journal information
  • Press
  • Permissions and reprints
  • Advertising

The European Respiratory Society

  • Society home
  • myERS
  • Privacy policy
  • Accessibility

ERS publications

  • European Respiratory Journal
  • ERJ Open Research
  • European Respiratory Review
  • Breathe
  • ERS books online
  • ERS Bookshop

Help

  • Feedback

For authors

  • Instructions for authors
  • Submit a manuscript
  • ERS author centre

For readers

  • Alerts
  • Subjects
  • RSS

Subscriptions

  • Accessing the ERS publications

Contact us

European Respiratory Society
442 Glossop Road
Sheffield S10 2PX
United Kingdom
Tel: +44 114 2672860
Email: journals@ersnet.org

ISSN

Online ISSN: 2312-0541

Copyright © 2021 by the European Respiratory Society